A mid-stage biotech consolidated fragmented intelligence sources, cut annual spending by 82%, and reduced decision latency from months to hours.
Meridian was paying for five separate intelligence subscriptions — and not getting coherent answers from any of them.
Market research from Vendor A said the peptide therapeutics space was consolidating. Competitive intelligence from Vendor B disagreed, citing different acquisition data. Regulatory tracking from Vendor C had a different timeline for FDA guidance. Clinical trial monitoring from Vendor D showed different Phase 2 readouts than clinical publication databases. Patent surveillance from Vendor E warned of IP challenges in their core space.
The result: five databases, five different conclusions, and zero agreed-upon truth.
When the VP of Strategy needed to assess a $3.2M licensing decision for a Phase 1.5 asset, she had five competing intelligence packages. One said "strong market demand, acquire it." Another said "oversaturated space, pass." A third was inconclusive because the competitive dataset was four weeks old. The decision loop stretched from August to December — four months of uncertainty while a licensing window closed and a competitor acquired the asset instead.
Annual intelligence spend: $847,000. Utilization: fragmented. Time to verified answer: 8-12 weeks. Accuracy: uncertain.
Meridian selected Cortex Shield tier and ran a 90-day integration program.
Cortex ingested Meridian's institutional knowledge: their pipeline, prior deals, competitive landscape taxonomy, regulatory filing timelines, partnership history. The system built a structured knowledge base of "what Meridian cares about."
Weekly briefings began. Not generic market reports, but Meridian-specific intelligence: Which of our competitors is hiring? Which regulatory agencies are affecting our pipeline? Which therapeutic areas are showing Phase 2 momentum? Which licensing signals matter to us?
Cortex Shield added continuous monitoring, source verification, and provenance scoring. Every claim had a source trail. Hallucinations were caught. The system built a reference library of "which vendors say what about which topics."
Leadership, BD, Research, and Regulatory teams were trained on accessing Cortex directly. Within 90 days, the five legacy systems were deprecated. All intelligence queries ran through a single, verified system.
Year 1 financial impact: $795,000 in annual savings. The Shield tier cost $52,000. Return on intelligence infrastructure: 15x.
The financial savings are obvious. But the operational impact was deeper:
Leadership moved faster. The CSO's decision latency dropped from 8 weeks to 48 hours. When a regulatory announcement lands, Meridian now knows the implications by end of business. When a competitor moves, the BD team detects it in real time, not in a trade publication. When a Phase 2 readout shifts the market, research strategy adjusts immediately.
Teams stopped arguing about what's true. Before Cortex, Meridian had 5 sources of truth. Now they have 1. No more "vendor A says X" vs. "vendor B says Y." No more triangulation paralysis. The single verified source gives everyone a shared operational reality.
Risk materialized earlier. Patent conflicts, regulatory changes, competitive moves — Meridian now detects these signals before they become crises. The two-week lag between their patent catch and their legacy system's catch was the difference between a manageable IP strategy adjustment and an emergency.
Intelligence became compounding. Each decision Meridian makes with Cortex trains the system further. The system knows their pipeline, their decision patterns, their therapeutic areas, their competitive set. Twelve months in, intelligence quality improves because institutional memory is structured and continuous, not scattered across five vendor databases.
Meridian reduced intelligence spend by 82% while accelerating decision quality. Learn how Cortex can do the same for your organization.
Request Access to Cortex